Healionics is a clinical-stage company addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of infection and occlusion suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 33 patents issued or pending.
Total raised: $14.7M
Founded date: 2007
Investors 11
Show more
Funding Rounds 3
| Date | Series | Amount | Investors |
| 22.02.2024 | Series A | $5.5M | - |
| 13.05.2021 | - | $4.7M | - |
| 24.09.2019 | - | $4.5M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 22.02.2024 | Healionics Closes $5.5 Million Series A-3 Financing Round | STARgraft vascular graft SEATTLE, WA, USA, February 22, 2024 /EINPresswire.com/ -- Healionics Corpor... | einpresswi... |
| 31.05.2022 | Tech Coast Angels’ Portfolio Company Healionics Honored with... | “We are thrilled that ACA has once again recognized a TCA portfolio company for its highest honor. I... | prweb.com/... |
| 13.05.2021 | Healionics Closes $4.7M Equity Financing | Healionics Corporation, a Seattle, WA-based private medical device company, closed a $4.7M equity fi... | finsmes.co... |
| 13.05.2021 | Healionics raises $4.7M equity round to support commercializ... | prnewswire... | |
| 13.05.2021 | Healionics raises $4.7M to commercialize artificial blood ve... | Healionics’ STARgraft vascular graft acts as an artificial blood vessel for dialysis patients. (Heal... | geekwire.c... |
| 24.09.2019 | Healionics Raises $4.5M in Funding | Healionics, a Seattle, WA-based medical device company, completed a $4.5M convertible note financing... | finsmes.co... |
| 28.02.2019 | Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX ... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints February may be the shortest month ... | xconomy.co... |
| 31.01.2008 | Life sciences briefing: Thursday, Jan. 31, 2007 | 5AM Ventures puts $3.3M into new immune-related startup — I’ve moved this item to a standalone post ... | venturebea... |
| - | Healionics | “Healionics - Innovative Solutions from Engineered Biomaterials” | fastfounde... |